Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ENROLLING BY INVITATION
NCT07163260

Defeat Rare Disease in Asia and Pacific (APAC) DRDA - Haemophilia

Sponsor: Novo Nordisk A/S

View on ClinicalTrials.gov

Summary

This study will help to better understand the course of disease in people with haemophilia (A or B \[with or without inhibitors\]) and the haemophilia care scenario in the selected countries and the experience so far in dealing with the condition. This is a survey-based study; hence no medications or other treatments will be provided to participants as a part of this study.

Key Details

Gender

All

Age Range

Any - Any

Study Type

OBSERVATIONAL

Enrollment

244

Start Date

2025-01-31

Completion Date

2025-12-19

Last Updated

2025-10-24

Healthy Volunteers

Not specified

Conditions

Interventions

OTHER

No treatment given

No treatment given

Locations (4)

Novo Nordisk Investigational Site

Bangalore, Karnataka, India

Novo Nordisk Investigational Site

Kuala Lumpur, Malaysia

Novo Nordisk Investigational Site

Seoul, South Korea

Novo Nordisk Investigational Site

Bangkok, Thailand